Chargement en cours...
Effects of Chitosan Oligosaccharide on Plasma and Hepatic Lipid Metabolism and Liver Histomorphology in Normal Sprague-Dawley Rats
Chitosan oligosaccharide is known to ameliorate hypercholesterolemia and diabetes. However, some studies found that chitosan oligosaccharide might induce mild to moderate hepatic damage in high-fat (HF) diet-induced obese rats or diabetic rats. Chitosan oligosaccharide can be as a dietary supplement...
Enregistré dans:
| Publié dans: | Mar Drugs |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7459944/ https://ncbi.nlm.nih.gov/pubmed/32748864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md18080408 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|